249 related articles for article (PubMed ID: 18767027)
1. Association of HPC2/ELAC2 and RNASEL non-synonymous variants with prostate cancer risk in African American familial and sporadic cases.
Robbins CM; Hernandez W; Ahaghotu C; Bennett J; Hoke G; Mason T; Pettaway CA; Vijayakumar S; Weinrich S; Furbert-Harris P; Dunston G; Powell IJ; Carpten JD; Kittles RA
Prostate; 2008 Dec; 68(16):1790-7. PubMed ID: 18767027
[TBL] [Abstract][Full Text] [Related]
2. Association of susceptibility alleles in ELAC2/HPC2, RNASEL/HPC1, and MSR1 with prostate cancer severity in European American and African American men.
Rennert H; Zeigler-Johnson CM; Addya K; Finley MJ; Walker AH; Spangler E; Leonard DG; Wein A; Malkowicz SB; Rebbeck TR
Cancer Epidemiol Biomarkers Prev; 2005 Apr; 14(4):949-57. PubMed ID: 15824169
[TBL] [Abstract][Full Text] [Related]
3. Single and multivariate associations of MSR1, ELAC2, and RNASEL with prostate cancer in an ethnic diverse cohort of men.
Beuten J; Gelfond JA; Franke JL; Shook S; Johnson-Pais TL; Thompson IM; Leach RJ
Cancer Epidemiol Biomarkers Prev; 2010 Feb; 19(2):588-99. PubMed ID: 20086112
[TBL] [Abstract][Full Text] [Related]
4. Association of hereditary prostate cancer gene polymorphic variants with sporadic aggressive prostate carcinoma.
Noonan-Wheeler FC; Wu W; Roehl KA; Klim A; Haugen J; Suarez BK; Kibel AS
Prostate; 2006 Jan; 66(1):49-56. PubMed ID: 16114055
[TBL] [Abstract][Full Text] [Related]
5. Evaluation of linkage and association of HPC2/ELAC2 in patients with familial or sporadic prostate cancer.
Xu J; Zheng SL; Carpten JD; Nupponen NN; Robbins CM; Mestre J; Moses TY; Faith DA; Kelly BD; Isaacs SD; Wiley KE; Ewing CM; Bujnovszky P; Chang B; Bailey-Wilson J; Bleecker ER; Walsh PC; Trent JM; Meyers DA; Isaacs WB
Am J Hum Genet; 2001 Apr; 68(4):901-11. PubMed ID: 11254448
[TBL] [Abstract][Full Text] [Related]
6. Mutational analysis of susceptibility genes RNASEL/HPC1, ELAC2/HPC2, and MSR1 in sporadic prostate cancer.
Nupponen NN; Wallén MJ; Ponciano D; Robbins CM; Tammela TL; Vessella RL; Carpten JD; Visakorpi T
Genes Chromosomes Cancer; 2004 Feb; 39(2):119-25. PubMed ID: 14695991
[TBL] [Abstract][Full Text] [Related]
7. Association between RNASEL, MSR1, and ELAC2 single nucleotide polymorphisms and gene expression in prostate cancer risk.
Alvarez-Cubero MJ; Pascual-Geler M; Martinez-Gonzalez LJ; Expósito Ruiz M; Saiz M; Cozar JM; Lorente JA
Urol Oncol; 2016 Oct; 34(10):431.e1-8. PubMed ID: 27318894
[TBL] [Abstract][Full Text] [Related]
8. Genetic variation in RNASEL and risk for prostate cancer in a population-based case-control study.
Fesinmeyer MD; Kwon EM; Fu R; Ostrander EA; Stanford JL
Prostate; 2011 Oct; 71(14):1538-47. PubMed ID: 21360564
[TBL] [Abstract][Full Text] [Related]
9. Association of RNASEL variants with prostate cancer risk in Hispanic Caucasians and African Americans.
Shook SJ; Beuten J; Torkko KC; Johnson-Pais TL; Troyer DA; Thompson IM; Leach RJ
Clin Cancer Res; 2007 Oct; 13(19):5959-64. PubMed ID: 17908993
[TBL] [Abstract][Full Text] [Related]
10. Contribution of HPC1 (RNASEL) and HPCX variants to prostate cancer in a founder population.
Agalliu I; Leanza SM; Smith L; Trent JM; Carpten JD; Bailey-Wilson JE; Burk RD
Prostate; 2010 Nov; 70(15):1716-27. PubMed ID: 20564318
[TBL] [Abstract][Full Text] [Related]
11. Loss of heterozygosity of the putative prostate cancer susceptibility gene HPC2/ELAC2 is uncommon in sporadic and familial prostate cancer.
Wu YQ; Chen H; Rubin MA; Wojno KJ; Cooney KA
Cancer Res; 2001 Dec; 61(24):8651-3. PubMed ID: 11751379
[TBL] [Abstract][Full Text] [Related]
12. Ser217Leu polymorphism of the HPC2/ELAC2 gene associated with prostatic cancer risk in Japanese men.
Takahashi H; Lu W; Watanabe M; Katoh T; Furusato M; Tsukino H; Nakao H; Sudo A; Suzuki H; Akakura K; Ikemoto I; Asano K; Ito T; Wakui S; Muto T; Hano H
Int J Cancer; 2003 Nov; 107(2):224-8. PubMed ID: 12949798
[TBL] [Abstract][Full Text] [Related]
13. Mutation screening and association study of RNASEL as a prostate cancer susceptibility gene.
Maier C; Haeusler J; Herkommer K; Vesovic Z; Hoegel J; Vogel W; Paiss T
Br J Cancer; 2005 Mar; 92(6):1159-64. PubMed ID: 15714208
[TBL] [Abstract][Full Text] [Related]
14. RNASEL and RNASEL-inhibitor variation and prostate cancer risk in Afro-Caribbeans.
Shea PR; Ishwad CS; Bunker CH; Patrick AL; Kuller LH; Ferrell RE
Prostate; 2008 Mar; 68(4):354-9. PubMed ID: 18189233
[TBL] [Abstract][Full Text] [Related]
15. Genetic analysis of the RNASEL gene in hereditary, familial, and sporadic prostate cancer.
Wiklund F; Jonsson BA; Brookes AJ; Strömqvist L; Adolfsson J; Emanuelsson M; Adami HO; Augustsson-Bälter K; Grönberg H
Clin Cancer Res; 2004 Nov; 10(21):7150-6. PubMed ID: 15534086
[TBL] [Abstract][Full Text] [Related]
16. ELAC2/HPC2 involvement in hereditary and sporadic prostate cancer.
Rökman A; Ikonen T; Mononen N; Autio V; Matikainen MP; Koivisto PA; Tammela TL; Kallioniemi OP; Schleutker J
Cancer Res; 2001 Aug; 61(16):6038-41. PubMed ID: 11507049
[TBL] [Abstract][Full Text] [Related]
17. ELAC2 polymorphisms and prostate cancer risk: a meta-analysis based on 18 case-control studies.
Xu B; Tong N; Li JM; Zhang ZD; Wu HF
Prostate Cancer Prostatic Dis; 2010 Sep; 13(3):270-7. PubMed ID: 20231859
[TBL] [Abstract][Full Text] [Related]
18. Association of HPC2/ELAC2 polymorphisms with risk of prostate cancer in a population-based study.
Stanford JL; Sabacan LP; Noonan EA; Iwasaki L; Shu J; Feng Z; Ostrander EA
Cancer Epidemiol Biomarkers Prev; 2003 Sep; 12(9):876-81. PubMed ID: 14504198
[TBL] [Abstract][Full Text] [Related]
19. HPC2/ELAC2 polymorphism associated with Japanese sporadic prostate cancer.
Yokomizo A; Koga H; Kinukawa N; Tsukamoto T; Hirao Y; Akaza H; Mori M; Naito S
Prostate; 2004 Nov; 61(3):248-52. PubMed ID: 15368467
[TBL] [Abstract][Full Text] [Related]
20. HPC2/ELAC2 gene variants associated with incident prostate cancer.
Adler D; Kanji N; Trpkov K; Fick G; Hughes RM
J Hum Genet; 2003; 48(12):634-638. PubMed ID: 14625808
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]